Platelet-Rich Fibrin Treatment Evaluation in Patients with Medication-Related Osteonecrosis of the Jaw and Osteoradionecrosis

• Published in: Journal of clinical medicine 2024-06, Vol.13 (12), p.3473
• Main Authors: Roman, Rareș Călin, Moldovan, Mădălina Anca, Pop, Loredana Sabrina, Megieșan, Sergiu, Faur, Cosmin Ioan
• Format: Article
• Language: English
• Subjects: Alcohol; Antibiotics; Bisphosphonates; Blood platelets; Bones; Care and treatment; Denosumab; Development and progression; Epidemiology; Evaluation; Fibrin; Fractures; Hospitals; Infections; Jaw diseases; Metastasis; Metronidazole; Monoclonal antibodies; Necrosis; Osteoporosis; Pain; Patient outcomes; Patients; Physiological aspects; Questionnaires; Radiation injuries; Radiation therapy; Statistical analysis; Surgery; Tobacco; Tumors
• ISSN: 2077-0383; 2077-0383
• DOI: 10.3390/jcm13123473

Medication-related osteonecrosis of the jaw (MRONJ) and osteoradionecrosis (ORN) are associated with severe disability and continuous pain, both of which are very difficult to control. This study aims to evaluate the outcome of platelet-rich fibrin (PRF) treatment compared to iodoform gauze packing and the primary suture of oral mucosa in patients with both MRONJ and ORN. Patients suffering from MRONJ and ORN who were treated in the Oral and Maxillofacial Surgery Clinic of Cluj-Napoca in the last 10 years were selected for this study from the hospital database. PRF treatment proved to be a reliable method to help heal the necrotic bone sites. High-ASA risk patients and immunosuppressed patients are more prone to recurrence and persistent signs and symptoms. Intravenous bisphosphonates produce more intense symptomatology compared to oral administration. The posterior mandible is more difficult to treat compared to other sites. The quality of life of MRONJ and ORN patients may be improved by a protocol that reduces pain and hospitalization.